Bronchoalveolar lavage cellularity in infants with severe respiratory syncytial virus bronchiolitis

Archives of Disease in Childhood

Volumn 88, Issue 10, 2003, Pages 922-926

  McNamara, P S ^b   Ritson, P ^a   Selby, A ^a   Hart, C A ^b   Smyth, R L ^a,b  

^a ALDER HEY CHILDREN S HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ARTIFICIAL VENTILATION; BIRTH; BRONCHIOLITIS; BRONCHOSCOPY; CALCULATION; CELL ACTIVITY; CONTROLLED STUDY; DISEASE SEVERITY; HUMAN; INFANT; INTUBATION; LEUKOCYTE DIFFERENTIAL COUNT; LUNG ALVEOLUS CELL; LUNG LAVAGE; MAJOR CLINICAL STUDY; PREMATURITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SAMPLING; STANDARDIZATION; TECHNIQUE; VIRUS INFECTION;

BRONCHIOLITIS, VIRAL; BRONCHOALVEOLAR LAVAGE FLUID; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; LEUKOCYTE COUNT; MALE; NEUTROPHILS; RESPIRATION, ARTIFICIAL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; SPECIMEN HANDLING;

EID: 0141636306     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.88.10.922     Document Type: Article

References (27)

1. Eriksson M, Bennet R, Rotzen-Ostlund M, et al. Population-based rates of severe respiratory syncytial virus infection in children with and without risk factors, and outcome in a tertiary care setting. Acta Paediatr 2002;91:593-8.
2. Martin AJ, Gardner PS, McQuillin J. Epidemiology of respiratory viral infection among paediatric inpatients over a six-year period in north-east England. Lancet 1978;2:1035-8.
3. Hall CB. Respiratory syncytial virus. In: Feigin RD, Cherry JD, eds. Textbook of paediatric infectious diseases. Philadelphia: WB Saunders, 1998:2084-111.
4. Openshaw PJ. Potential therapeutic implications of new insights into respiratory syncytial virus disease. Respir Res 2002;3:S15-20.
5. Navas L, Wang E, Robinson J. Improved outcome of respiratory syncytial virus infection in a high-risk hospitalized population of Canadian children. Pediatric Investigators Collaborative Network on Infections in Canada. J Pediatr 1992;121:348-54.
6. Gavin R, Anderson B, Percival T. Management of severe bronchiolitis: indications for ventilator support. N Z Med J 1996;109:137-9.
7. de Sierra TM, Kumar ML, Wasser TE, et al. Respiratory syncytial virus-specific immunoglobulins in preterm infants. J Pediatr 1993;122:787-91.
8. Nievas FF, Chernick V. Bronchopulmonary dysplasia [chronic lung disease of infancy): an update for the pediatrician. Clin Pediatr (Phila) 2002;41:77-85.
9. Jobe AJ. The new BPD: an arrest of lung development. Pediatr Res 1999;46:641-3.
10. Kimpen JL, Ogra PL. T cell redistribution kinetics after secondary infection of BALB/c mice with respiratory syncytial virus. Clin Exp Immunol 1993;91:78-82.
11. Openshaw PJ. Flow cytometric analysis of pulmonary lymphocytes from mice infected with respiratory syncytial virus. Clin Exp Immunol 1989;75:324-8.
12. Taylor G, Stott EJ, Hayle AJ. Cytotoxic lymphocytes in the lungs of mice infected with respiratory syncytial virus. J Gen Virol 1985;66(pt 12):2533-8.
13. Taylor G, Thomas LH, Stott EJ. Effect of vaccination on cell populations in lung washes from calves after infection with respiratory syncytial virus. Res Vet Sci 1989;47:231-5.
14. Everard ML, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch Dis Child 1994;71:428-32.
15. Smith PK, Wang SZ, Dowling KD, et al. Leucocyte populations in respiratory syncytial virus-induced bronchiolitis. J Paediatr Child Health 2001;37:146-51.
16. Aherne W, Bird T, Court SD, et al. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970;23:7-18.
17. Kim HW, Canchola JG, Brandt CD, et al. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine. Am J Epidemiol 1969;89:422-34.
18. de Blic J, Midulla F, Barbato A, et al. Bronchoalveolar lavage in children. ERS Task Force on bronchoalveolar lavage in children. European Respiratory Society. Eur Respir J 2000;15:217-31.
19. Shann F, Pearson G, Slater A, et al. Paediatric index af mortality (PIM): a mortality prediction model for children in intensive care. Intensive Care Med 1997;23:201-7.
20. Buckingham SC, Jafri HS, Bush AJ, et al. A randomized double-blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus [RSV) infection: effects on RSV quantity and clinical outcome. J Infect Dis 2002;185:1222-8
21. van den Hoogen BG, de Jong JC, Groen J, et al. A newly discovered human pneumavirus isolated fram young children with respiratory tract disease. Nat Med 2001;7:719-24.
22. Greensill J, McNamara PS, Dove W, et al. Human metapneumovirus in severe respiratory syncytial virus bronchiolitis. Emerg Infect Dis 2003;9:372-5.
23. Cherukupalli K, Larson JE, Rotschild A, et al. Biochemical, clinical, and morphologic studies on lungs of infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;22:215-29.
24. Wang SZ, Hallsworth PG, Dowling KD, et al. Adhesion molecule expression on epithelial cells infected with respiratory syncytial virus. Eur Respir J 2000;15:358-66.
25. Wang SZ Forsyth KD. The interaction of neutrophils with respiratory epithelial cells in viral infection. Respirology 2000;5:1-10.
26. Wang SZ, Xu H, Wraith A, et al. Neutrophils induce damage to respiratory epithelial cells infected with respiratory syncytial virus. Eur Respir J 1998;12:612-18.
27. Hussell T, Pennycook A, Openshaw PJ. Inhibition of tumor necrosis factor reduces the severity of virus-specific lung immunopathology. Eur J Immunol 2001;31:2566-73.